These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9636489)
41. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495 [No Abstract] [Full Text] [Related]
42. Is cyclosporine toxic to the transplanted kidney with acute tubular necrosis? Ritz M; Pascoe MD; Pontin AR; Kahn D Transplant Proc; 1998 Jun; 30(4):1204. PubMed ID: 9636488 [No Abstract] [Full Text] [Related]
43. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224 [TBL] [Abstract][Full Text] [Related]
44. Posttransplant serum creatinine area under the curve predicts renal allograft outcome. Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260 [No Abstract] [Full Text] [Related]
45. Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation. Kaden J; May G; Strobelt V; Groth J; Müller P Transplant Proc; 1997; 29(1-2):344-7. PubMed ID: 9123032 [No Abstract] [Full Text] [Related]
46. Cyclosporine from twice to single daily dosing: impact on renal function, mortality, and graft loss. Bianco PD; Silva HT; Boni R; Machado PG; Pacheco-Silva A; Pestana JO Transplant Proc; 2002 Nov; 34(7):2920-1. PubMed ID: 12431657 [No Abstract] [Full Text] [Related]
47. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related]
49. Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation. Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D Transplant Proc; 1998 Jun; 30(4):1170-2. PubMed ID: 9636473 [No Abstract] [Full Text] [Related]
50. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years. MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774 [No Abstract] [Full Text] [Related]